Gene. 2013 Jun 15;522(2):226-30. doi: 10.1016/j.gene.2013.03.059. Epub 2013 Apr 6.
Myotonic dystrophy is a progressive multisystem genetic disorder affecting about 1 in 8000 people worldwide. The unstable repeat expansions of (CTG)n or (CCTG)n in the DMPK and ZNF9 genes cause the two known subtypes of myotonic dystrophy: (i) myotonic dystrophy type 1 (DM1) and (ii) myotonic dystrophy type 2 (DM2) respectively. There is currently no cure but supportive management helps equally to reduce the morbidity and mortality and patients need close follow up to pay attention to their clinical problems. This review will focus on the clinical features, molecular view and genetics, diagnosis and management of DM1.
强直性肌营养不良症是一种进行性多系统遗传性疾病,影响全球约每 8000 人中有 1 人。在 DMPK 和 ZNF9 基因中的不稳定重复扩展(CTG)n 或(CCTG)n 导致两种已知的强直性肌营养不良症亚型:(i)强直性肌营养不良症 1 型(DM1)和(ii)强直性肌营养不良症 2 型(DM2)。目前尚无治愈方法,但支持性治疗同样有助于降低发病率和死亡率,患者需要密切随访以注意其临床问题。这篇综述将重点介绍 DM1 的临床特征、分子观点和遗传学、诊断和管理。